Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
Submitted by
admin
on February 17, 2012 - 9:05am
Source:
TheStreet.com
News Tags:
Vivus
Chelsea Therapeutics
Keryx
Biocryst
Exelixis
BioSante
Headline:
Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
Do Not Allow Advertisers to Use My Personal information
